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REVIEW CURRENTOPINION The anesthesiologist and end-of-life care0952-7907  2012 Wolters Kluwera,b bSebastiano Mercadante and Antonello GiarratanoPurpose of review
Anesthesiologists may face problematic situations when patients are close to death, in which clinical
problems, decision-making processes, and ethical issues are often interconnected and dependent on each
of them. The aim of this review is to assess the recent literature regarding the anesthesiological role for
advanced cancer patients.
Recent findings
Palliative sedation in the dying patients, end-of-life problems in the ICU, and pain control in advanced
cancer patients have been the subject of recent research. All these issues have shown that anesthesiologist
would be expert in the field of pain and symptom control at the end of life. End-of-life care problems are
common in ICU, and a decision-making process requires knowledge and management of patients’ wishes,
past and projected future quality of life, severity and prognosis of illness, patients’ age, regarding
withholding and withdrawing of futile treatments in anticipation of death, or relieving symptoms close to
death.
Summary
Anesthesiologists should be competent in all aspects of terminal care, including the practical and ethical
aspects of withdrawing different modalities of life-sustaining treatment and the use of sedatives, analgesics,
and nonpharmacologic approaches to easing the suffering of the dying process. More research is needed
to provide models which should be spread in the scientific community to afford this difficult task.
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Anesthesiologists may face problematic situations,
in which clinical problems, decision-making pro-
cesses, and ethical issues are often interconnected
and dependent on each of them. Although it would
be desirable that anesthesiologists would be expert
in the field of pain and symptom control at the
end of life, work load is often an insurmountable
obstacle to a direct and continuous care of advanced
cancer patients. In most cases, consultations are
performed to provide advice for difficult cases
or interventional procedures. Moreover, end-of-life
care problems are common in the ICU, and decision-
making process requires knowledge and manage-
ment of patients’ wishes, past and projected future
quality of life, severity and prognosis of illness,
patients’ age, regarding withholding and withdraw-
ing of futile treatments in anticipation of death, or
relieving symptoms close to death. The aim of this
review is to assess the recent literature regarding the
anesthesiological role for advanced cancer patients.
Very few studies assessed this topic, particularly in
the last year, underlining the need of much research
in this field.Health | Lippincott Williams & WilkDIFFICULT TASKS IN ADVANCED CANCER
PATIENTS
An example of a complex decision-making
process is recurrent malignant bowel obstruction.
Bowel obstruction because of recurrent cancer is
commonly associated with poor long-term survival.
Surgical attempts to relieve malignant obstruc-
tion have a significant morbidity and mortality,
and variable success in resolving symptoms. The
presence of carcinomatosis strongly influences
surgical prognosis. Surgical intervention in patients
with peritoneal carcinomatosis produces rather
short-term success with significant mortality and
morbidity rates related to the procedure, rangingins www.co-anesthesiology.com
KEY POINTS
 ICU clinicians should be competent in all aspects of the
end-of-life care.
 Integration of palliative care experts into the operation
of ICUs may be of benefit to patients, families, and
critical care clinicians.
 Communication issues with the relatives are essential,
as an appropriate relationship improves patient care
and family outcomes in the last days of life, allowing us
to share the same objectives and expectations.
Anesthesia and medical diseasebetween 14–29 and 37–45%, respectively. Apart
from obstruction, peritoneal carcinomatosis may
cause motility problems because of intestinal para-
lysis secondary to extensive tumor involvement
of the intestinal mesentery and plexuses, which is
not cured by surgical procedures. Survival rates
of medically versus surgically treated patients
have been found to be not significantly different.
Anesthesiologists should be aware that in any
case, expected survival time is not necessarily an
absolute factor for decision-making, as deterioration
of patients’ condition in the postoperative period,
suffering from complications and hospitalization,
in other terms, quality of life, should also be taken
into account. Postoperative complications include
wound infections and dehiscence, sepsis, enterocu-
taneous fistula, further obstruction, peritoneal
abscess, anastomosis dehiscence, gastrointestinal
bleeding, pulmonary embolism, and deep venous
thrombosis. Successful palliation in terms of dura-
tion of maintenance of intestinal transit and gastro-
intestinal symptom control is the most important
outcome. These factors are difficult to explore
in comparison with the standard key-points of
prognosis, like mortality and morbidity rates, while
quality-of-life measurements remain difficult to
apply in this context. Prognostic criteria are difficult
to apply in a condition that is highly variable
individually, whose assessment is not uniformly
recognized, approaches as well as diagnostic and
therapeutic choices are dependent on the setting,
definition of the outcome is rarely afforded, and
available data on survival prognosis of the illness
cannot be drawn for practical scoring. The multi-
disciplinary approach, including the opinion of
the anesthesiologist and the surgeon, as well as
an expert in palliativemedicine, is rarely performed,
and despite the possible poor prognosis, surgery is
often performed, because it is considered inevitably
as an imperative act (otherwise the patient will die).
Surgery should be justified on the basis of more372 www.co-anesthesiology.combenefit rather than burden to patients, based on
the prognostic factors available, and consent to
surgery should include discussion of risks, compli-
cations, as well as medical alternatives, effective in
relieving the symptoms [1
&&
].
Patients who are considered inoperable after
a careful consideration of the individual clinical
condition should be managed in a different context
addressing the quality-of-life issues, rather than sur-
vival. The pharmacological management of malig-
nant bowel obstruction in inoperable malignant
bowel obstruction focuses on the relief of nausea
and vomiting, pain, and other possible distressing
symptoms. It principally consists of an association
of antiemetics, antisecretory drugs, and analgesics.
In bowel obstruction, a combination of cortico-
steroids and antisecretory agents is commonly used.
Specifically, an anticholinergic drug or octreotide
may reduce, by different mechanisms, pain com-
plaints due to abdominal distension, other than
decreasing gastrointestinal secretion [1
&&
].TERMINAL SEDATION
Although sedation for symptom relief in terminally
ill patients has been the focus of recent medical
studies, the interpretation of research findings
is difficult because of confusing terminology.
Palliative sedation therapy should be considered
as the use of sedative medications to relieve
intolerable and refractory distress by the reduction
in patient’s consciousness. This should not be
confounded with a slow euthanasia when clinicians
sedate patients approaching the end of life with
the primary goal of hastening the patient’s death.
Rather, there is no proof that sedation is associated
with a shorter survival [2
&
]; thus, the concept of the
double effect, which should justify the intent of
the good effect (relieving suffering), should not be
the determinant. This practice is universally used
in the ICU for short periods, but not considered
as definitive as in this case. In palliative setting, this
practice is common, ranging in about 10–50% of
dying patients depending on the setting. Most cen-
ters use a midazolam-based regimen because of the
drug’s short half-life, ease of intravenous or subcu-
taneous administration, and good efficacy. Opioids
should not be used for the primary purpose of
sedation, but rather should be continued for analge-
sic purposes or doses tailored to control dyspnea [3
&
].END-OF-LIFE PROBLEMS IN THE
INTENSIVE CARE UNIT
Dying has changed as a process over the last century
in terms of causes of death, costs, communication ofVolume 25  Number 3  June 2012
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Nearly half of Americans who die in hospitals spend
time in the ICU in the last 3 days of life [4
&
]. The
consequent possibility of manipulating the dying
process has generated many problems, which
range from the necessity of rationing scarce and
expensive resources to the definition of optimal care
for dying people and the necessity of redefining
death itself. As a consequence, actions should be
accompanied by careful bioethical reflection [5
&
].
The ICU represents a hospital setting in which
death and discussion about the end-of-life care are
common, yet these conversations are often difficult.
Minority patients who die in the ICU are less
likely to formalize advance directives, and surviving
family members report lower satisfaction with the
provision of information and sensitivity to their
cultural traditions at the end of life [4
&
]. Such
difficulties arise, in part, because a family may be
facing an unexpected poor prognosis associated
with an acute illness or exacerbation and, in part,
because the ICU orientation is one way of saving
lives. Understanding and improving communi-
cation about the end-of-life care between clinicians
and families in the ICU is an important focus
for improving the quality of care in the ICU.
Unfortunately, a considerable variation in the
apparent willingness of consultants to make end-
of-life decisions has been reported, emphasizing the
subjective nature of these decisions [6]. High-quality
care for the ICU patients and their families includes
palliative care. Quality indicators of palliative care
processes, such as identification ofmedical decision-
maker, advance directive and resuscitation prefer-
ence, distributing family information leaflet, assess-
ing and managing pain, offering social work and
spiritual support, and conducting an interdiscipli-
nary family meeting, have been measured in the
ICU. The performance was inconsistent and
infrequent, other than pain assessment and man-
agement [7
&&
].
ICU clinicians should be competent in all
aspects of this care, including the practical and
ethical aspects of withdrawing different modalities
of life-sustaining treatment and the use of sedatives,
analgesics, and nonpharmacologic approaches to
easing the suffering of the dying process. Recom-
mendations based on ethical and legal principles,
rather than deriving from evidence, have been
developed to improve the care for the ICU patients
during the dying process [8]. In a study investigating
influencing decisions to withdraw life support,
rather than age or the severity of the illness and
organ dysfunction, the strongest determinants
of the withdrawal of ventilation in critically ill
patients were the physician’s perception that the0952-7907  2012 Wolters Kluwer Health | Lippincott Williams & Wilkpatient preferred not to use life support, the
physician’s prediction of a low likelihood of survival
in the ICU and a high likelihood of poor cognitive
function, and the use of inotropes or vasopressors
[9]. A total of 55% of ICU deaths were the result
of treatment withdrawal. Overwhelmingly, treat-
ment failure or futility was the reason cited for
withdrawal. There were no cases of conflict
between the medical team and the patient’s family.
Consultation with the ICU colleagues was rated
as the most helpful factor in decision-making [10].
In a study of policies of withholding and withdrawal
of life-sustaining treatment in critically ill patients
on cardiac ICUs, cranial computed tomography
with poor prognosis, multiorgan failure, and failure
of assist device therapy were the most frequently
citedmedical reasons for withholding or withdrawal
of life-sustaining treatments, while poor expected
quality of life, the patient’s willingness to limit
medical care, and the family’s choice were the top
ethical reasons [11].
The knowledge of the distinctions betweenwith-
holding and withdrawing treatments, between
actions of killing and allowing to die, and between
consequences that are intended and those that
are merely foreseen is of paramount importance.
Communication issues with the relatives are
essential, as an appropriate relationship improves
patient care and family outcomes in the last days
of life, allowing to share the same objectives and
expectations. Respect for patient autonomy and the
intention to honor decisions to decline unwanted
treatments should be conveyed to the family. If a
conflict cannot be resolved, an ethics consultation
may be helpful [12]. The effectiveness of discussions
that take place between clinicians and family
members becomes a crucial marker of high-quality
intensive care [13].
Another aspect linked to the end-of-life care
in the ICU includes the ability for notifying families
of a patient’s death and compassionate approaches
for discussing the options for organ donation.
Comprehensive bereavement programs to support
both families and the needs of the clinical staff
should be included in the educational curricula
for improving the end-of-life care in the ICU.
An audit study demonstrated the feasibility of
developing a quality improvement tool [14] for
the end-of-life decision-making in the intensive care
setting. The potential for strained communications
is mitigated, if clinicians provide timely clinical
and prognostic information and support family
with continuous psychological support. Effective
communication includes sharing the burden of
decision-making with family members. This shift
from individual responsibility to patient-focusedins www.co-anesthesiology.com 373
Anesthesia and medical diseaseconsensus often permits the family to understand
that intensive caring may involve letting go of
life-sustaining interventions [15]. Family members’
informal roles are part of families’ decision-making
processes, as they determine the complicated family
dynamics within the family system and between
the family and heath care domains. Identification
and description of these informal roles of family
members can help the physician recognize and
understand the functions of these roles in families’
decision-making at the end of life and guide the
development of strategies to support and facilitate
increased effectiveness of family discussions and
decision-making processes [16
&
]. Other demographic
variables should be considered among the visitors
at the ICU. For example, professionals should pay
special attention to the needs of younger visitors
to the ICU, women, and those with a low level
of education, as they may require more support,
comfort, and proximity [17].
Integration of palliative care experts into the
operation of ICUs may be of benefit to patients,
families, and critical care clinicians. A palliative
care team dramatically changed the way to treat
dying patients in the ICU in comparison with
patients who died without a palliative care con-
sultation [4
&
]. Education on the death process was
provided to 85% of families by the project team.
A total of 29% of patients were disconnected
from mechanical ventilators following consultation
with the Palliative Care Service: 15.9% of patients
discontinued the use of inotropic support, 15.3%
stopped artificial nutrition, 6.4% stopped dialysis,
and 2.5% discontinued artificial hydration. Recom-
mendations on pain management were made for
51% of the project’s patients and symptommanage-
ment for 52% of patients. The project was associated
with an increase in the rate of the formalization of
advance directives. A total of 33% of the patients
who received palliative care consultations had ‘do
not resuscitate’ orders in place prior to consultation
and 83.4% had ‘do not resuscitate’ orders after the
intervention. The project team referred 80 (51%) of
the project patients to hospice and 55 (35%) patients
were enrolled on hospice, primarily at the medical
center. The mean time from admission to palliative
care consultation at the project site was 2.8 versus
15.5 days at the other campus without a palliative
care team. Median survival times from admission to
the medical center were not significantly different.
Median charges for the use of opioid medications
were higher for the intervention group but lower
for use of laboratory and radiology tests. This
study suggests that such models may be associated
with improved quality of life, higher rates of formal-
ization of advanced directives and utilization of374 www.co-anesthesiology.comhospices, as well as lower use of certain non-
beneficial life-prolonging treatments for critically
ill patients who are at the end of life.PAIN CONTROL IN ADVANCED CANCER
PATIENTS
When symptoms are severe, anesthesia-pain
medicine and palliative medicine can effectively
treat the symptoms. In a small study, the palliative
medicine group resulted in being more effective in
symptom management and improving the quality
of life, in comparison with the anesthesia-pain
medicine group, the differences in pain relief being
less relevant [18
&
]. This small study suggests that
anesthesiologists require a more comprehensive
knowledge about the problems of advanced cancer
patients, as symptom management could be sub-
optimal. On the other hand, interventional pro-
cedures are performed by skilled people, commonly
anesthesiologists. Although the need of these tech-
niques has been decreasing in the last years, because
of a better knowledge about the use of opioids and a
better drug availability, this does not mean that the
selected population would be proposed for an inter-
ventional procedure. Only 25% of anesthesiologists’
job plans had time allocated for palliative medicine
referrals [19]. A small numberofpatientsmay still fail
to obtain adequate analgesia despite large systemic
opioid doses or they may suffer from uncontrollable
side-effects such as nausea, vomiting, or over-
sedation. Nerve blocks, neuroaxial infusions, and
radiofrequency ablations are viable options to
enhance the pain control in cancer patients.
Minimally invasive vertebral procedures have been
proposed in recent years to provide pain relief.
However, risks may be of concern, particularly in
the advanced stage of disease. For example, the
interruption of sympathetic nervous system to treat
pain is the least innocuous block in terms of com-
plications. However, it has been shown that a neuro-
lytic sympathetic plexus block is more efficacious
when considered earlier in the disease [20]. Neural
blockade is performed in a minority of patients
who receive specialized palliative care. Common
procedures included epidurals, neurolytic plexus
block, and intrathecal nerve block with phenol [21].
In the 1990s, spinal analgesia has been described
as a useful means to control pain in advanced
cancer patients. Despite a lack of clinical evidence,
spinal analgesia with a combination of opioids,
principally morphine, and local anesthetics may
allow us to achieve analgesia in patients who had
been intensively treated unsuccessfully with differ-
ent trials of opioids. Some adjuvant drugs such as
clonidine, ketamine, betamethasone, meperidine,Volume 25  Number 3  June 2012
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several problems have to be solved before they
can be used in daily practice. In complex pain
situations, spinal analgesia should not be negated
to cancer patients, and oncologists should address
this group of patients to anesthesiologists [22].CONCLUSION
Anesthesiologists should be competent in all aspects
of palliative care and the end of life, including
the practical and ethical aspects of withdrawing
different modalities of life-sustaining treatment
and the use of sedatives, analgesics, and non-
pharmacologic approaches to easing the suffering
of the dying process. Integration of palliative
care experts into the operation of ICUs may be
of benefit to patients, families, and critical care
clinicians.Acknowledgements
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